77Z-27747-67250 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-26
Dose 1 — Moderna
2021-02-24
Dose 2 — Moderna
2021-05-05
Registered in v-safe
2022-02-24
Dose 3 — Moderna
2022-02-24
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in
2022-08-25
Health check-in — 6 months, dose 3
Feeling: Good

Adult check-in
2023-02-24
Survey response — 12 months, dose 3
MedDRA: Headache, Nasopharyngitis, Oropharyngeal pain — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

MedDRA releases: 2024-11
2023-02-24
Report sent to call center — 12 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Emergency room or emergency department visit · 1 call case(s)
2023-02-27
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-26	Moderna
2	2021-02-24	Moderna
3	2022-02-24	Moderna	No

Call center

Reported	Outcome	VAERS-related outcome
2023-02-24	Unsuccessful

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Headache	·	·	✓
SD	Nasopharyngitis	·	·	✓
SD	Oropharyngeal pain	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release